This isn't about casual experimentation
A major clinical trial showed patients taking oral semaglutide lost approximately 35% of their body weight over 26 weeks, with some individuals achieving greater reductions through consistent diet and exercise adherence
They should be prescribed and monitored by clinicians familiar with peptide therapy, your medical history, medications, and risk factors
Some of these medications include: Ozempic (semaglutide) Mounjaro (tirzepatide) Saxenda (liraglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Saxenda, Wegovy, and Zepbound are FDA-approved for weight management, while other GLP-1 medications are used primarily for Type 2 diabetes and are sometimes prescribed off-label for weight loss
With free shipping directly to patients homes, the clinic ensures that busy schedules or travel constraints never stand in the way of progress toward better health
Its always a great idea to consult a healthcare professional before starting any peptide regimen